An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Treatment Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers market the substance there before redirecting buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source.
Some experts said the demand for the experimental drug could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.
Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to fines, legal action or prison.
Platform Reaction and Content Removal
According to the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The organization said it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within moments of joining one group, a seller shared contact information, where most transactions occur. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.
Product Information and Pricing
Inside these communities, posts show dark colored packages with Royal Mail labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram stated it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to possibly serious health risks”.
